LINDSAY BYRNE: Open Payments
NPI 1962259887 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $614 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $225 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $167 |
| Novartis Pharmaceuticals Corporation | 1 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $109 |
| Amgen Inc. | 1 | $102 |
| ABIOMED | 1 | $101 |
| CVRx, Inc. | 2 | $90 |
Products named: LifeVest, LEQVIO, MITRACLIP, Kerendia, Repatha, Barostim Neo System, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across NV — which companies pay providers there.
